State-of-the-art management of dysplastic Barrett's esophagus
Sign Up to like & getrecommendations! Published in 2022 at "Gastroenterology Report"
DOI: 10.1093/gastro/goac068
Abstract: Abstract Endoscopic eradication therapy (EET) has become a standard of care for treatment of dysplastic Barrett’s esophagus (BE) and early Barrett’s neoplasia. EET mainly consists of removal of any visible lesions via endoscopic resection and… read more here.
Keywords: barrett esophagus; endoscopic; barrett; dysplastic barrett ... See more keywords
Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2022-001091
Abstract: Objective Barrett’s oesophagus (BO) is a precursor lesion, via dysplastic phases, to oesophageal adenocarcinoma. Although overall risk from BO is low, it has been shown to adversely affect health-related quality of life (HRQOL). The aim… read more here.
Keywords: dysplastic barrett; group; pre group; quality life ... See more keywords